BioWraptor closes $1.5M pre-seed to advance room-temperature stabilization of biologics, with backing from Anima x Alpha Star and SNOCAP.
Amount Raised
$1.5 Million
Round Type
Pre-Seed
New YorkBiotechnologyHealth CareInvestors
Description
BioWraptor, a biotechnology company developing technology to stabilize fragile biomolecules at room temperature, announced the close of a $1.5 million pre-seed round. The round was led by investors including Anima x Alpha Star, SNOCAP, NY Ventures, and angel investors Pascal and Bérengère Marguet, Ryan Jeffery, and Dolgin and Greg Haar. The funding will support expanded laboratory capabilities to accelerate customer pilots and product commercialization. The company's technology takes inspiration from tardigrades and aims to reduce or eliminate refrigeration needs for healthcare products, vaccines, and biologics.
Quick answer
BioWraptor raised $1.5 Million in a Pre-Seed round, dated November 12, 2026. Investors: Greg Haar, Dolgin, Ryan Jeffery, Bérengère Marguet, Pascal Marguet, NY Ventures, Snocap and Anima x Alpha Star. BioWraptor is based in New York, New York, United States.
- How much did BioWraptor raise?
- BioWraptor raised $1.5 Million in a Pre-Seed round on November 12, 2026.
- Who invested in BioWraptor?
- Greg Haar, Dolgin, Ryan Jeffery, Bérengère Marguet, Pascal Marguet, NY Ventures, Snocap and Anima x Alpha Star are named as investors in this round.
- What does BioWraptor do?
- BioWraptor is a biotechnology company developing technology to stabilize fragile biomolecules at room temperature using naturally derived building blocks inspired by tardigrades.
- Where is BioWraptor based and how big is it?
- BioWraptor is based in New York, New York, United States.
Source: Fundz verified event record.
Who else raised in Biotechnology and Health Care around the same time
Companies in the same sectors as BioWraptor that raised within 45 days of this round, from Fundz verified event records.
- Orakl Oncology raised $34M (Series A) on November 12, 2026.
- Skribe Medical raised $1.6M (Pre-Seed) on November 12, 2026.
- Prime Medicine raised $135M (Post-IPO Equity) on November 12, 2026.
- Neurosterix raised $105M (Series B) on November 11, 2026.
- Kardi Ai raised $5.9M (Series A) on November 11, 2026.
- Switchpoint Bio raised $5.3M (Pre-Seed) on November 11, 2026.
Who to call at BioWraptor, and when
A new round usually means BioWraptor is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day BioWraptor raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at BioWraptor, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at BioWraptor. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment BioWraptor raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
BioWraptor raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.